Assessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spouses

Basit Öğe Kaydı
dc.authorid0000-0003-0655-0989en_US
dc.authorid0000-0003-0544-4906en_US
dc.authorid0000-0002-2648-2824en_US
dc.contributor.authorÇelepkolu, T.
dc.contributor.authorBucaktepe, P. Gamze Erten
dc.contributor.authorYılmaz, A.
dc.contributor.authorPervane, V. D.
dc.contributor.authorBatmaz, İ.
dc.contributor.authorSarıyıldız, M. A.
dc.date.accessioned2023-07-05T12:47:07Z
dc.date.available2023-07-05T12:47:07Z
dc.date.issued2021en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Aile Hekimliği Ana Bilim Dalıen_US
dc.description.abstractAbstract. – OBJECTIVE: Fibromyalgia syndrome (FMS) is a chronic disease that is more common in adult women and is characterized by widespread pain in the body, especially in the musculoskeletal system. Fatigue, sleep disturbance, anxiety disorder, and depression can be observed in this syndrome alongside pain. The aim of our study was to investigate the effect of FMS on the quality of life, psychological condition, and sleep quality of affected female patients and their spouses compared to women without FMS and their spouses. PATIENTS AND METHODS: Thirty female patients diagnosed with fibromyalgia and their spouses and 38 healthy women and their spouses similar in age to these patients voluntarily participated in our study (136 participants total). The diagnosis of the patients was made according to the American College of Rheumatology. Turkish versions of the Short Form-36 (SF36), the Hospital Anxiety and Depression Scale, and the Pittsburgh Sleep Quality Index (PSQI) questionnaires with validity and reliability were applied to all participants. The statistical analyses were carried out using SPSS 24.0 for Windows (SPSS Inc., Chicago, IL, US). Differences with p-values of ≤0.05 were statistically significant, and all results are expressed with a 95% confidence interval. RESULTS: A total of 136 people, including women with FMS (n=30), spouses of FMS women (n=30), non-FMS control women (n=38), and spouses of the control women (n=38), were included in the study. The patient and control groups were similar in age and gender. However, participants in the study group had higher mean Body Mass Indexes compared to the controls. Quality of life and its sub-scales (except SF-36/Social function parameter), depression, anxiety status, and sleep quality were significantly different between the patients and controls. Additionally, quality of life and its sub-scales (except SF-36/Social function parameter), depression, and anxiety status were significantly different between the spouses of the patients and controls. There were no significant differences between the groups regarding the mean SF-36/SF (p=0.995 for both). Additionally, there was no significant difference between the spouse of the patient and control regarding the mean PSQI values (p=0126). CONCLUSIONS: We believe that new and more comprehensive studies are necessary regarding the spouses of women with FMS in depression, anxiety, sleep quality disorders that we frequently see in women with FMS, and other psychosocial conditions that we have not mentioned here. In conclusion, women with FMS and their spouses.en_US
dc.identifier.citationÇelepkolu, T., Bucaktepe, P.G.E., Yılmaz, A., Pervane, V.D., Batmaz, İ. ve Sarıyıldız, M.A. (2021). Assessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spouses. European Review for Medical and Pharmacological Sciences, 25(13), 4506-4513.en_US
dc.identifier.doi10.26355/eurrev_202107_26242
dc.identifier.endpage4513en_US
dc.identifier.issn1128-3602
dc.identifier.issue13en_US
dc.identifier.pmid34286508
dc.identifier.scopus2-s2.0-85110637413
dc.identifier.scopusqualityQ2
dc.identifier.startpage4506en_US
dc.identifier.urihttps://www.europeanreview.org/wp/wp-content/uploads/4506-4513.pdf
dc.identifier.urihttps://hdl.handle.net/11468/12194
dc.identifier.volume25en_US
dc.identifier.wosWOS:000796011600001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorÇelepkolu, Tahsin
dc.institutionauthorBucaktepe, P. Gamze Erten
dc.institutionauthorYılmaz, Ahmet
dc.institutionauthorPervane, V. D.
dc.institutionauthorBatmaz, İbrahim
dc.language.isoenen_US
dc.publisherVerduci Publisheren_US
dc.relation.ispartofEuropean Review for Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFibromyalgia syndromeen_US
dc.subjectSpousesen_US
dc.subjectDepressionen_US
dc.subjectAnxietyen_US
dc.subjectQuality of lifeen_US
dc.titleAssessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spousesen_US
dc.titleAssessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spouses
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Assessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spouses.pdf
Boyut:
382.91 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu